Stalwart Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 16.89%
- Profit Growth 31.03%
- Ebitda 4.61%
- Net Worth 35.78%
- Total Assets 46.50%
About Stalwart Meditech
Stalwart Meditech Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 August 2014 and has a history of Ten years and five months. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek and Ashish Goel serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51101DL2014PTC270487
- Company No.
270487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Stalwart Meditech Private Limited offer?
Stalwart Meditech Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, Doppler Machine, Forceps & Graspers, Electrosurgical Unit, Medical Electrodes, Urological & Obstetrics Instruments, Gynecology Instrument, Endoscopy Instruments, Surgical & ICU Equipments, Dermatology Equipment.
Who are the key members and board of directors at Stalwart Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek  | Director | 19-Aug-2014 | Current |
| Ashish Goel | Director | 19-Aug-2014 | Current |
Financial Performance of Stalwart Meditech.
Stalwart Meditech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.89% increase. The company also saw a substantial improvement in profitability, with a 31.03% increase in profit. The company's net worth Soared by an impressive increase of 35.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stalwart Meditech?
In 2023, Stalwart Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stalwart Meditech?
Unlock and access historical data on people associated with Stalwart Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stalwart Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stalwart Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
